INTRODUCTION
Asthma is, a common complex disease, characterized by chronic inflammation of airway, variable airflow limitation, repetitive cough, wheezing, shortness of breath and chest tightness (1) . Asthma is associated with considerable morbidity, avoidable mortality and substantial costs to society (2) . According to the estimation Although environmental factors play key role in the pathogenesis of asthma, there are multiple reported genes which confer susceptibility to this disease (5, 6) . Owing to complexity, it has been difficult to identify the genetic basis of such complex genetic disorders and yet, the genetic contribution of asthma disease is remained to be investigated (7) . Accumulating evidence suggest that immune system cells such as TH17 cells and their related cytokines are involved in the pathophysiology of asthma (8, 9) . These data emphasize the prominent role of cytokines and their receptors in promotion of allergy and asthma (10) (11) (12) .
IL-10 is a cytokine derived from CD4 + T-helper type 2 (TH2) cells (13, 14) identified as a suppressor of cytokines from T-helper type 1 (TH1) cells (15, 16) . IL-10 contributes in the pathophysiologic mechanism of inflammatory disease since it has been shown to regulate both cellular and humoral immunity (17) .
Distinct responses of IL-17-producing cells in inflammatory conditions (18) together with its increase in lung lesions (19, 20) , highlighted the potential involvement of IL-17 in asthma (21) and potentiality it could be a modifier gene specific to asthma. In addition, IL-17 family   members including IL-17A, IL-17B, IL-17C, IL-17D, IL-17E, and IL-17F (22, 23) are known to be important regulator of neutrophilic inflammation (24) and aberration in their production may drive severe forms of the disease (21, 25) .
Among IL-17 family members, the expression patterns and function of IL-17A is not well understood.
In this study, we evaluated the expression alteration of Interleukin-10 (IL-10) and Interleukin-17A (IL-17A) in some categories of asthma patients with different level of severity versus healthy controls. 
MATERIALS AND METHODS

Patients and control
RNA preparation of Peripheral Blood Mononuclear Cells
Three milliliters of whole blood were taken and To examine genes expression of interleukins 17A (IL- 
Data analysis
All statistical analyses were performed using the Further studies of larger patient cohorts and blood samples are needed to confirm and explain these findings and study of correlation between expression and the protein of target genes would be interesting.
